With 1.4 billion people, 22 languages and 900 million social media users, India is one of the world’s most complex markets. Success here demands a deep understanding of the market and cultural nuances, and strategic engagement across business, government and society.
We.’s India agencies, Avian We. and Chase India, are trusted partners to global brands, investors and policymakers. We combine strategic communications, policy advocacy, data analytics and social impact strategies to shape narratives, influence decision-making and drive real impact.
Although our clients rely on our expertise across a wide range of industry sectors, disciplines, and communications platforms and practices, here are some where we really stand out.
Corporate reputation and thought leadership
Policy and stakeholder advocacy
Social impact and sustainability
Healthcare communications
Crisis and risk management
Digital innovation and experiential storytelling
Insights, analytics and intelligence
Thought leadership and research
Nitin Mantri
Regional Executive Managing Director for Asia-Pacific, We. and Group CEO, Avian We.
2024
Masters Consultancy (Winner)
2021, 2022, 2023, 2024
Best Organisation for Women Empowerment
2024
India PR Agency of the Year (Silver)
Chase India, in partnership with Global Counsel, has published the report which calls for transformative financial and policy frameworks that support and empower women as agents of climate resilience.
Consciously Speaking stands as a pioneering resource that bridges a critical gap in India's journey toward LGBTQIA+ inclusion.
For biotech and pharmaceutical companies, maintaining a strong corporate reputation requires more than delivering high-quality, safe medicines.
Chase India, in partnership with Global Counsel, has published the report which calls for transformative financial and policy frameworks that support and empower women as agents of climate resilience.
Consciously Speaking stands as a pioneering resource that bridges a critical gap in India's journey toward LGBTQIA+ inclusion.
For biotech and pharmaceutical companies, maintaining a strong corporate reputation requires more than delivering high-quality, safe medicines.
